{
  "id": 20274999,
  "title": "Sofinnova closes second crossover fund at €725M for late-stage European biotechs",
  "url": "https://urgent.news/2026/11/16/sofinnova-closes-second-crossover-fund-at-725m-for-late-stage",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T07:00:17.000Z",
  "source": {
    "name": "Endpoints News",
    "slug": "endpoints-news",
    "url": "https://endpoints.news/sofinnova-closes-second-crossover-fund-at-e725m-for-late-stage-european-biotechs/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Sofinnova Partners has secured €725 million ($815 million) for its second crossover fund, which it said would fill the financing gap for late-stage European biopharma and medtech companies. Europe has the science and the companies ...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}